Syneos Health, Inc.
SYNHDelisted Sep 28, 2023- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001610950
Syneos Health, Inc. was delisted on Sep 28, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 317 institutions reported holding it in 13F filings for Q2 2023, worth $4.32B in total; superinvestors Elliott Investment Management and Southeastern Asset Management (Longleaf) held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 317
- Q2 2023, +12 vs. previous quarter
- 13F value
- $4.32B
- Reported value at the end of Q2 2023
- Superinvestors holding
- 2
- At the end of Q2 2023
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2022
- $5.39B
- +3.5% year over year
- Net income, FY2022
- $266.5M
- +13.5% year over year
- Free cash flow, FY2022
- $333.5M
- −15.2% year over year
- Revenue, Q2 FY2023
- $1.37B
- +0.4% year over year
Revenue flow, FY2022
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Superinvestors holding SYNH, Q2 2023
Go to the superinvestors tab2 superinvestors report holding Syneos Health, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Elliott Investment Management
Paul Singer
1.7%
Syneos Health, Inc.'s share of the portfolio
- Shares
- 3,299,476
- Value
- $139.0M
Southeastern Asset Management (Longleaf)
Mason Hawkins
<0.1%
Syneos Health, Inc.'s share of the portfolio
- Shares
- 19,655
- Value
- $828.3K
Latest insider trades
See all insider tradesOpen-market purchases and sales by Syneos Health, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 (view filing) | Jul 28 | 1 day | Brooks Michael LeeChief Operating Officer | SSaleClass A Common Stock | −1.00K | $78.00 | −$78.2K | −2.1%47.6K after | |
| Jul 29, 2022 (view filing) | Jul 28 | 1 day | Brooks Michael LeeChief Operating Officer | SSaleClass A Common Stock | −500 | $78.00 | −$39.0K | −5.1%9.34K after | |
| Jul 22, 2022 (view filing) | Jul 21 | 1 day | Brooks Michael LeeChief Operating Officer | SSaleClass A Common Stock | −1.00K | $76.00 | −$76.2K | −2.0%48.6K after | |
| Jul 22, 2022 (view filing) | Jul 21 | 1 day | Brooks Michael LeeChief Operating Officer | SSaleClass A Common Stock | −500 | $76.00 | −$38.0K | −4.8%9.84K after | |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Olefson JonathanGeneral Counsel & Corp Secty | SSaleClass A Common Stock | −2.21K | $75.00 | −$166.1K | −8.1%25.3K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Brooks Michael LeeChief Operating Officer | SSaleClass A Common Stock | −1.00K | $74.00 | −$74.1K | −2.0%49.6K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Brooks Michael LeeChief Operating Officer | SSaleClass A Common Stock | −500 | $74.00 | −$37.0K | −4.6%10.3K after | |
| Jul 20, 2022 (view filing) | Jul 18 | 2 days | Keefe MichelleChief Executive Officer | SSaleClass A Common Stock | −8.33K | $72.81 | −$606.7K | −10.5%71.3K after | |
| Jul 20, 2022 (view filing) | Jul 18 | 2 days | Meggs Jason M.Chief Financial Officer | SSaleClass A Common Stock | −7.50K | $72.81 | −$546.1K | −12.1%54.7K after | |
| Jul 11, 2022 (view filing) | Jul 8 | 3 days | Kralowetz Donna HildebrandEVP, Chief Accounting Officer | SSaleClass A Common Stock | −1.15K | $73.16 | −$84.1K | −14.4%6.80K after |
Top 10 13F holders, Q2 2023
See all 317 holdersThe largest institutional positions in Syneos Health, Inc. at the end of Q2 2023; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 10,283,488 | $433.3M | 0.01% | −165,675−1.6% | Reduced |
| BlackRock Inc. | 9,930,430 | $418.5M | 0.01% | −575,313−5.5% | Reduced |
| Barclays PLC | 4,664,940 | $196.6M | 0.13% | +1,604,446+52.4% | Added |
| UBS Oconnor LLC | 3,342,622 | $140.9M | 2.98% | +3,342,622 | New |
| Elliott Investment Management L.P.SuperinvestorElliott Investment Management | 3,299,476 | $139.0M | 1.66% | +3,299,476 | New |
| HBK Investments L P | 3,250,000 | $137.0M | 4.35% | +3,250,000 | New |
| Farallon Capital Management, L.L.C. | 3,075,000 | $129.6M | 0.77% | +2,603,000+551.5% | Added |
| State Street Corp | 2,885,944 | $121.6M | 0.01% | +31,564+1.1% | Added |
| Glazer Capital, LLC | 2,352,886 | $99.2M | 6.56% | +2,352,886 | New |
| Two Sigma Advisers, LP | 2,033,100 | $85.7M | 0.22% | +1,168,100+135.0% | Added |
Politician trades
All politician trades in SYNH4 members of Congress reported 8 trades in Syneos Health, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Feb 24, 2023 | Daniel S. Goldman House · NY | Sell | $1K-$15K |
| Feb 17, 2023 | Josh Gottheimer House · NJ | Sell | $1K-$15K |
| Jan 13, 2023 | Josh Gottheimer House · NJ | Sell (partial) | $1K-$15K |
| Dec 29, 2022 | Susie Lee House · NV | Sell | $1K-$15K |
| Feb 18, 2022 | Josh Gottheimer House · NJ | Sell (partial) | $1K-$15K |

House · NY · Feb 24, 2023
Sell$1K-$15K

House · NJ · Feb 17, 2023
Sell$1K-$15K

House · NJ · Jan 13, 2023
Sell (partial)$1K-$15K

House · NV · Dec 29, 2022
Sell$1K-$15K

House · NJ · Feb 18, 2022
Sell (partial)$1K-$15K